However, upon sustained TMZ treatment, both genetic and phenotypic plasticities towards adaptive resistance were observed in MGMT promoter hypermethylated GBM cell lines whereas MGMT-hypomethylated cells demonstrated very limited plasticity to further adaptive resistance. This evidence concerns the gene MGMT and glioblastoma.